--- title: 'People Intern at REGENXBIO' canonical: 'https://feeny.ai/job/people-intern-regenxbio-rockville-mq2tm3vcjxe7' type: 'job' last_seen: '2026-11-02' --- # People Intern at REGENXBIO - **Company:** REGENXBIO - **Location:** Rockville, MD - **Employment:** internship - **Work type:** hybrid - **Posted:** 2026-09-30 - **Last confirmed live:** 2026-11-02 - **Apply:** https://jobs.lever.co/regenxbio/4669880d-7813-47ec-ad05-159129ae7d3a ## Job description Since our founding in 2009, REGENXBIO has pioneered what’s possible in gene therapy. Today, we are advancing a pipeline of gene therapies designed to improve the lives of patients facing serious rare and retinal diseases and preparing to bring innovative new medicines to patients. Our work is fueled by purpose and urgency because every day matters to patients and their families. At REGENXBIO, you’ll find meaningful opportunities to grow, collaborate, and contribute to the advancement of potentially transformative gene therapies. Together, our talented team is working to make a meaningful difference for patients and their families. What we do matters. The opportunity REGENXBIO is looking for a curious, motivated, and highly organized Intern to join our People (HR) team. This part-time opportunity is designed for a college senior approaching graduation or a recent college graduate who is interested in building a career in Human Resources and is eager to gain meaningful, hands-on experience inside a growing biotechnology company. You’ll work approximately 20-30 hours per week, with flexibility to accommodate your class schedule. You’ll support initiatives across talent acquisition, onboarding and employee experience, People operations, communications, data and analytics, and special projects. We’re looking for someone who’s excited to grow with us. This internship has the potential to lead to a full-time opportunity on our People team in the new year. The role is based in our Rockville, Maryland office. Candidates must be able to work onsite part-time during the internship and transition to full-time, onsite work after graduation to be considered for a full-time opportunity. ## How you'll contribute - Support employee lifecycle administration in UKG, including processing new hires and terminations under the guidance of the People team, with a focus on accuracy and timely updates. - Create and maintain employee files and People documentation, ensuring accuracy, organization and confidentiality. - Support the People-side administration of the contractor onboarding and renewal process, partnering closely with Legal and Procurement to coordinate requirements, documentation, approvals, and timely completion. - Assist with recruiting activities, including drafting and posting job ads, coordinating interviews and candidate communications, maintaining recruitment files, and closing postings. - Coordinate onboarding activities, including scheduling New Hire Orientation, preparing materials, ordering swag and welcome boxes, and supporting day-of logistics. - Support offboarding administration, including preparing termination notices for review and coordinating related communications and documentation. - Assist with People processes, HR systems, reporting, and data quality, and identify opportunities to improve efficiency. - Take ownership of assigned special projects that enhance the employee experience, bringing fresh ideas to People programs and practices. ## What you'll bring We are looking for someone who is eager to learn and contribute in a collaborative, patient-focused environment. Ideal candidates will bring: - Current college senior or recent college graduate with a bachelor’s degree in Human Resources, Business, Psychology, Communications, Organizational Development, or a related field. - Interest in building a career in Human Resources and availability to work approximately 20 hours per week. - Availability to potentially transition to full-time employment in early to mid-2027. - Strong organizational skills and attention to detail, with the ability to manage multiple priorities and follow through on commitments. - Strong  written and verbal communication skills and the ability to collaborate with people across teams and levels. - Comfort working with data, learning new systems and the using Microsoft Office, including Excel, PowerPoint, Outlook and Word. - Curiosity, initiative, and a willingness to ask questions. - Good judgment and discretion when handling sensitive employee information. - Previous HR experience is not required. We welcome relevant skills development through coursework, campus leadership, internships, part-time jobs, volunteer experience, and other experiences. ## What you can expect At REGENXBIO, we're committed to fostering an environment where people can do meaningful work, grow professionally, and make an impact. Our core values – trust, accountability, perseverance, and innovation – drive everything we do. The estimated hourly rate for this internship is $22–$24 per hour. The actual rate offered will be determined based on the selected candidate’s year in school. ## About REGENXBIO ## Company Overview - **One-liner**: REGENXBIO is a clinical-stage biotechnology company developing one-time gene therapies for rare and retinal diseases using its proprietary AAV vector platform. - **Entity Type**: Public (NASDAQ: RGNX) - **Headquarters**: Rockville, Maryland, United States - **Founded**: 2008 (founded as a company; operations began in 2009) - **Founders**: Not publicly listed as individual founders; the company was spun out from the gene therapy research of the University of Pennsylvania and licensed its NAV Technology Platform from the university. ## Core Business - **Primary industry**: Biotechnology – Gene Therapy (AAV-based) - **Target customers**: B2B (pharma partners like AbbVie, Nippon Shinyaku) and B2G (regulatory agencies, clinical trial sites); ultimate customers are patients with rare and retinal diseases (Duchenne muscular dystrophy, MPS I, MPS II, wet AMD, diabetic retinopathy). - **Mission or purpose statement**: “To improve lives through the curative potential of gene therapy.” [regenxbio.com](https://www.regenxbio.com/culture-careers/) ## Products & Services - **NAV® Technology Platform**: Proprietary AAV vector gene delivery platform (including AAV8 and AAV9) used for internal programs and licensed to partners (e.g., Novartis for ZOLGENSMA®). - **ABBV-RGX-314** (in collaboration with AbbVie): Investigational one-time gene therapy for wet age-related macular degeneration (wet AMD) and diabetic retinopathy (DR). In pivotal clinical trials. - **RGX-202** (Duchenne muscular dystrophy): Phase I/II/III AFFINITY DUCHENNE® trial; pivotal phase expected to support BLA submission in 2026 using accelerated approval pathway. [ir.regenxbio.com](https://ir.regenxbio.com/static-files/92731f97-50e3-4285-b793-d2cdc99611aa) - **RGX-121** (MPS II – Hunter syndrome): In partnership with Nippon Shinyaku; late-stage development. - **RGX-111** (MPS I – Hurler syndrome): In partnership with Nippon Shinyaku; clinical development. - **Manufacturing**: In-house cGMP production facility (REGENXBIO Manufacturing Innovation Center – RMIC) in Rockville, MD, operational since mid-2022. ## Market Standing - **Valuation/Market Cap**: $447.8 million (as of recent data). [linkedin.com](https://linkedin.com/company/regenx) - **Key Metric**: Annual Revenue $170.4 million (primarily from license and collaboration revenue). [linkedin.com](https://linkedin.com/company/regenx) - **Notable Investors/Partners**: - AbbVie (collaboration for ABBV-RGX-314) - Nippon Shinyaku (partnerships for RGX-121 and RGX-111) - Novartis (licensee for ZOLGENSMA® using NAV vectors) - **Growth Signals**: - Headcount: 296 employees (+1.3% YoY). [linkedin.com](https://linkedin.com/company/regenx) - BLA submission for RGX-202 targeted for 2026. - RMIC facility operational since 2022, enabling scalable clinical and commercial manufacturing. - Scholarly output: 160 works, 7,337 citations, field-weighted citation impact of 2.6 (highly influential). [linkedin.com](https://linkedin.com/company/regenx) ## Competitive Advantages - **Proprietary NAV Technology Platform**: Exclusive rights to a large portfolio of AAV vectors (including AAV8 and AAV9), the foundation for multiple approved and investigational gene therapies. [ir.regenxbio.com](https://ir.regenxbio.com/static-files/92731f97-50e3-4285-b793-d2cdc99611aa) - **End-to-end capabilities**: Integrated in-house R&D, preclinical development, clinical development, and cGMP manufacturing. - **Proven platform**: Thousands of patients have been treated with AAV vectors from the NAV platform (including via Novartis’ ZOLGENSMA®). - **Late-stage pipeline**: Multiple programs in pivotal or near-pivotal trials (RGX-202, ABBV-RGX-314) with clear regulatory pathways. ## Strategic Focus - **Near-term**: Advance RGX-202 toward BLA submission in 2026; continue pivotal trials for ABBV-RGX-314 in wet AMD and diabetic retinopathy. - **Long-term**: Expand pipeline in retinal, neuromuscular, and neurodegenerative diseases; leverage RMIC for commercial-scale manufacturing; deepen partnerships with AbbVie and Nippon Shinyaku. - **Platform expansion**: Ongoing research to expand NAV vector capabilities and develop new AAV-based therapies. ## Why Work Here - **Mission-driven culture**: “Patient-focused, driven by results, fosters collaboration.” Core values emphasize accountability, innovation, and serving patients with limited therapeutic options. [regenxbio.com](https://www.regenxbio.com/culture-careers/) - **Impactful work**: Opportunity to work on one-time gene therapies that could fundamentally alter the course of devastating diseases. - **Growth & stability**: Public company with late-stage pipeline, strong partnerships, and a clear path to commercialization. - **Location & facilities**: Headquarters in Rockville, MD, with a state-of-the-art cGMP manufacturing facility (RMIC) on site. - **Work policy**: Not explicitly stated as remote/hybrid; positions appear to be on-site (based on job listings in Rockville and field-based Medical Science Liaison roles). - **Perks**: Comprehensive and competitive benefits for employees and families. [regenxbio.com](https://www.regenxbio.com/culture-careers/) - **Engineering & science culture**: High scholarly output and citation impact; emphasis on cross-functional collaboration between research, manufacturing, and clinical teams. - **Recruitment note**: REGENXBIO warns of fraudulent job offers; all applications go through their official Lever portal. [regenxbio.com](https://www.regenxbio.com/culture-careers/) ## Sources 1. [regenxbio.com – Culture & Careers](https://www.regenxbio.com/culture-careers/) 2. [linkedin.com – REGENXBIO company page](https://linkedin.com/company/regenx) 3. [ir.regenxbio.com – 10-K Filing (Business Overview)](https://ir.regenxbio.com/static-files/92731f97-50e3-4285-b793-d2cdc99611aa) 4. [ir.regenxbio.com – Investor Overview](https://ir.regenxbio.com/investor-overview) 5. [jobs.lever.co – REGENXBIO careers](https://jobs.lever.co/regenxbio) ## Other roles at REGENXBIO - [Lead Integration Developer](https://feeny.ai/job/lead-integration-developer-regenxbio-rockville-x52a6y2n5b0w) — Rockville, MD - [VP, Global Rare Disease Franchise](https://feeny.ai/job/vp-global-rare-disease-franchise-regenxbio-remote-zw2996mdrwy4) - [Vice President, Information Technology](https://feeny.ai/job/vice-president-information-technology-regenxbio-rockville-ekqdx4dtve6s) — Rockville, MD - [Associate Director, Regulatory Affairs](https://feeny.ai/job/associate-director-regulatory-affairs-regenxbio-rockville-1grfyr3vz4sy) — Rockville, MD - [Head of Sales, Rare Disease](https://feeny.ai/job/head-of-sales-rare-disease-regenxbio-remote-qhp7fgpvfvzm) - [Associate Director, People Business Partner](https://feeny.ai/job/associate-director-people-business-partner-regenxbio-rockville-fmx3gbzx681y) — Rockville, MD - [Director, Commercial Data, Advanced Analytics & Forecasting](https://feeny.ai/job/director-commercial-data-advanced-analytics-forecasting-regenxbio-remote-88y6fvc5kv5j) - [Associate Director, Rare Disease Product Marketing](https://feeny.ai/job/associate-director-rare-disease-product-marketing-regenxbio-rockville-r2p05phcvmx8) — Rockville, MD - [Senior Director, Global Program Development Lead - DMD/Neuromuscular](https://feeny.ai/job/senior-director-global-program-development-lead-dmd-neuromuscular-regenxbio-xbereeg0zrc8) — Rockville, MD - [Senior Director/Director, Medical Science Liaisons (Neuromuscular/DMD)](https://feeny.ai/job/senior-director-director-medical-science-liaisons-neuromuscular-dmd-regenxbio-aeca83gb75e2)